Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombosis in heritable hemolytic disorders.

J E Barker1, N J Wandersee

  • 1The Jackson Laboratory, Bar Harbor, ME 04609, USA.

Current Opinion in Hematology
|March 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in Clara cell 10 kDa protein (CC10)-positive cell distribution in acute lung injury following repeated lipopolysaccharide challenge in the rat.

Toxicologic pathology·2008
Same author

Effects of kaolin particle film on Myzus persicae (Hemiptera: Aphididae) behaviour and performance.

Bulletin of entomological research·2007
Same author

Electrocardiographic and other cardiac anomalies in beta-glucuronidase-null mice corrected by nonablative neonatal marrow transplantation.

Proceedings of the National Academy of Sciences of the United States of America·2004
Same author

Donor cell replacement in mice transplanted in utero is limited by immune-independent mechanisms.

Blood cells, molecules & diseases·2003
Same author

Murine recessive hereditary spherocytosis, sph/sph, is caused by a mutation in the erythroid alpha-spectrin gene.

The hematology journal : the official journal of the European Haematology Association·2002
Same author

Downeast anemia (dea), a new mouse model of severe nonspherocytic hemolytic anemia caused by hexokinase (HK(1)) deficiency.

Blood cells, molecules & diseases·2002
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Thrombotic events are a serious risk for patients with hemolytic anemias like sickle cell disease. Multiple interacting factors, not just the anemia itself, contribute to this coagulation crisis.

Area of Science:

  • Hematology
  • Vascular Biology
  • Genetics

Background:

  • Thromboses are a severe complication in patients with hemolytic anemias, including sickle cell disease, paroxysmal nocturnal hemoglobinuria, and beta-thalassemia.
  • Despite prophylactic measures, thrombotic events persist, leading to significant morbidity and mortality.
  • The variable occurrence of thrombosis in hemolytic anemias suggests a multifactorial etiology involving complex interactions.

Purpose of the Study:

  • To explore the complex interplay of factors contributing to thrombophilia in patients with hemolytic anemias.
  • To identify genetic and environmental risk factors for thrombotic events in these patient populations.
  • To advance understanding of the mechanisms underlying thrombogenesis in the context of hemolytic anemias.

Main Methods:

Related Experiment Videos

  • Examination of mutations in genetic modifiers of coagulation as risk factors.
  • Identification of red blood cell binding sites on endothelial cells.
  • Development and utilization of mouse models for experimental thrombogenesis studies.

Main Results:

  • Recent research has focused on genetic modifiers influencing coagulation response.
  • Specific red cell-endothelial cell interactions involved in thrombosis have been elucidated.
  • Novel mouse models enable the investigation of single-factor impacts on thrombogenesis.

Conclusions:

  • Thrombophilia in hemolytic anemias results from a complex interaction of genetic, environmental, and disease-specific factors.
  • Ongoing research is identifying key genetic modifiers and cellular interactions contributing to thrombotic risk.
  • Experimental models are crucial for dissecting the multifactorial causes of thrombosis in these conditions.